HTG Molecular Diagnostics has collaborated with John Wayne Cancer Institute (JWCI) to market its HTG melanoma signature assays. The signature assays may be useful for diagnostic and prognostic applications along the melanoma ...
Tags: HTG melanoma signature assays, clinical technology, clinical research
HTG Molecular Diagnostics has gained rights to commercialize the Centre of Excellence for the Prevention of Organ Failure's(PROOF Centre)-developed gene expression blood tests,following the finalization of the license agreement. The gene ...
Tags: HTG Molecular Diagnostics, Prevention of Organ Failure, COPD, qNPA
HTG Molecular Diagnostics is set to launch the fully-automated EDGE system at the AMP conference, which will be held in Long Beach, California, US, from 25-27 October 2012. The instrument, which is designed for use in clinical and ...
Tags: fully-automated EDGE system, EDGE instrument, AMP conference
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency virus (HIV). The COBAS TaqMan HIV-1 ...
Tags: Viral Load Test, Dual-target HIV-1 Viral Load Test, Roche
HTG Molecular Diagnostics has licensed Merck's breast cancer marker to develop, manufacture, and market breast cancer diagnostic tests. HTG Molecular Diagnostics CEO TJ Johnson said the ability to quickly, and locally assess a patient's ...
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Roche's new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus' (CMV) DNA in human plasma specimens. The real-time ...
Tags: Roche, FDA, Viral Load Test, PCR-based CMV test